Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  American Journal of Medicine

• Publication date

  2004-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AMJMED.2003.07.017PMID 14715322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Subjective assessment of the effects of CNS‐active drugs on sleep by the Leeds sleep evaluation questionnaire: a review

  2003cited by this paper
• Peak of circadian melatonin rhythm occurs later within the sleep of older subjects.

  2002cited by this paper
• IS MELATONIN CIRCADIAN RHYTHM A PHYSIOLOGICAL FEATURE ASSOCIATED WITH HEALTHY LONGEVITY? A STUDY OF LONG-LIVING SUBJECTS AND THEIR PROGENY

  2001cited by this paper
• Melatonin in older people with age-related sleep maintenance problems: a comparison with age matched normal sleepers.

  2001cited by this paper
• ACTIGRAPHIC SLEEP-WAKE PATTERNS AND URINARY 6-SULFATOXYMELATONIN EXCRETION IN PATIENTS WITH ALZHEIMER'S DISEASE

  2001cited by this paper
• Determining the minimum clinically significant difference in visual analog pain score for children.

  2001cited by this paper
• SF-36: Evaluation of Quality of Life in Severe and Mild Insomniacs Compared With Good Sleepers

  2001cited by this paper
• Do plasma melatonin concentrations decline with age?

  2000cited by this paper
• Prevalence of insomnia in a survey of 12 778 adults in France

  2000cited by this paper
• Low urinary 6‐sulphatoxymelatonin levels in patients with coronary artery disease

  2000cited by this paper
• Nocturnal melatonin secretion and its modification by treatment in patients with sleep disorders.

  1999cited by this paper
• The relationship between 6‐sulphatoxymelatonin and polysomnographic sleep in good sleeping controls and wake maintenance insomniacs, aged 55–80 years

  1999cited by this paper
• Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I.

  1999cited by this paper
• Normative melatonin excretion: a multinational study.

  1999cited by this paper
• Urinary 6‐sulfatoxymelatonin excretion and aging: New results and a critical review of the literature

  1999cited by this paper
• Prevalence and health consequences of insomnia.

  1999cited by this paper
• Quality of life in people with insomnia.

  1999cited by this paper
• Do plasma melatonin concentrations decline with age?

  1999cited by this paper
• Decreased melatonin synthesis in patients with coronary artery disease.

  1999cited by this paper
• The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement.

  1998cited by this paper
• Melatonin excretion is not related to sleep in the elderly

  1998cited by this paper
• Melatonin: marvel or marker?

  1998cited by this paper
• 6‐Sulfatoxymelatonin excretion and self‐reported sleep in good sleeping controls and 55–80‐year‐old insomniacs

  1998cited by this paper
• Sleep deprivation response in seasonal affective disorder during a 40-h constant routine.

  1998cited by this paper
• Melatonin deficiency and its implications for the treatment of insomnia in elderly subjects

  1998cited by this paper
• Effect of atenolol on nocturnal sleep and temperature in young men: reversal by pharmacological doses of melatonin.

  1997cited by this paper
• Form, frequency and burden of sleep problems in general health care: a report from the WHO Collaborative Study on Psychological Problems in General Health Care

  1996cited by this paper
• Nocturnal Melatonin Secretion and Sleep after Doxepin Administration in Chronic Primary Insomnia

  1996cited by this paper
• Melatonin replacement therapy of elderly insomniacs.

  1995cited by this paper
• Impaired nocturnal secretion of melatonin in coronary heart disease.

  1995cited by this paper
• Improvement of sleep quality by melatonin.

  1995cited by this paper
• Improvement of sleep quality in elderly people by controlled-release melatonin.

  1995cited by this paper
• Sleep disorders and melatonin rhythms in elderly people

  1994cited by this paper
• The Mini-Mental State Examination score and the clinical diagnosis of dementia.

  1994cited by this paper
• Association of sleep-wake habits in older people with changes in output of circadian pacemaker.

  1992cited by this paper
• Subjective total insomnia: an example of sleep state misperception.

  1992cited by this paper
• Neuroendocrine rhythms and sleep in aging men.

  1991cited by this paper
• Effect of melatonin replacement on serum hormone rhythms in a patient lacking endogenous melatonin.

  1991cited by this paper
• Circadian rhythms of melatonin and cortisol in aging.

  1989cited by this paper
• Alterations in nocturnal serum melatonin levels in humans with growth and aging.

  1988cited by this paper
• Suppression of Nocturnal Plasma Melatonin and 6-Sulphatoxymelatonin by Bright and Dim Light in Man

  1987cited by this paper
• Plasma melatonin--an index of brain aging in humans?

  1986cited by this paper
• Problems in Defining Response in Therapy Studies

  1986cited by this paper
• Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol.

  1985cited by this paper
• Differentiating anxiety and depression in anxiety disorders: use of rating scales.

  1982cited by this paper
• Self-reports versus sleep laboratory findings in 122 drug-free subjects with complaints of chronic insomnia.

  1976cited by this paper
• REPLICATION OF FACTORS OF PSYCHOPATHOLOGY IN INTERVIEW, WARD BEHAVIOR AND SELF‐REPORT RATINGS OF HOSPITALIZED DEPRESSIVES

  1969cited by this paper

• Predicting Insomnia Response to Acupuncture With the Development of Innovative Machine Learning

  2025cites this paper
• Neurochemical Insights into the Role of Tryptophan Metabolites and Kynurenine Pathway in Insomnia and its Psychological and Neurological Comorbidities

  2025cites this paper
• [Biomarkers of aging mechanisms].

  2025cites this paper
• The use of prolonged-release melatonin in circadian medicine: a systematic review.

  2024cites this paper
• Nutritional Supplements for Healthy Aging: A Critical Analysis Review

  2024cites this paper
• Impact of Earthquake on Cardiovascular Health: What Should Cardiovascular Healthcare Providers Anticipate After the Devastating Earthquakes in Turkey and Syria?

  2023cites this paper
• The dim light melatonin onset across ages, methodologies, and sex and its relationship with morningness/eveningness

  2023cites this paper
• Effects of Prolonged Use of β-Adrenoblockers on Melatonin Secretion, Sleep Quality, and Vascular Brain Damage

  2022cites this paper
• The role of exogenous melatonin in the regulation of sleep

  2022cites this paper
• Sleep Quality and Its Determinants Among Type 2 Diabetes Patients with Comorbid Metabolic Syndrome

  2022cites this paper
• Evaluation of multiple reaction monitoring cubed performed by a quadrupole-linear ion trap mass spectrometer for quantitative determination of 6-sulfatoxymelatonin in urine.

  2022cites this paper
• The Influence of Sleep Disturbance on Chronic Pain

  2022cites this paper
• Melatonin as a Chronobiotic with Sleep-promoting Properties

  2022cites this paper
• Circadian Disruption and Occupational Toxicants Exposure Affecting the Immunity of Shift Workers During SARS CoV-2 Pandemic

  2022cites this paper
• A Series of Remote Melatonin Supplement Interventions for Poor Sleep: Protocol for a Feasibility Pilot Study for a Series of Personalized (N-of-1) Trials

  2022cites this paper
• Could Melatonin Be an Alternative to Benzodiazepine for Chronic Obstructive Pulmonary Disease With Insomnia?

  2022cites this paper
• Emerging Therapeutics Agents and Recent Advances in Drug Repurposing for Alzheimer's Disease.

  2022cites this paper
• Melatonin and healthy aging.

  2021cites this paper
• Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials

  2021cites this paper
• Melatonin and Phytomelatonin: Chemistry, Biosynthesis, Metabolism, Distribution and Bioactivity in Plants and Animals—An Overview

  2021cites this paper
• Melatonin supplementation in the subacute phase after ischemia alleviates postischemic sleep disturbances in rats

  2021cites this paper
• [The effect of long-term beta-blockers on melatonin secretion, sleep quality, and vascular brain damage].

  2021cites this paper
• Effects of Melatonin on Salivary Levels of Cortisol and Sleep Quality of Hemodialysis Patients: A Randomized Clinical Trial

  2021cites this paper
• Sleep and Immunity

  2021cites this paper
• La mélatonine (MEL) et son utilisation dans les pathologies neurologiques et l’insomnie : recommandations de la Société française de recherche et de médecine du sommeil (SFRMS)

  2021cites this paper
• Cytoprotection by Melatonin: The Metabolic Syndrome as an Example

  2021cites this paper
• RETRACTED ARTICLE: Ameliorating effect of melatonin against nicotine induced lung and heart toxicity in rats

  2021cites this paper
• Melatonin Patterns and Levels During the Human Menstrual Cycle Melatonin Patterns and Levels During the Human Menstrual Cycle and After Menopause and After Menopause

  2021cites this paper
• Melatonin Patterns and Levels During the Human Menstrual Cycle and After Menopause

  2020cites this paper
• Melatonin supplementation in the management of obesity and obesity-associated disorders: a review of physiological mechanisms and clinical applications.

  2020cites this paper
• [Sleep and immunity].

  2020cites this paper
• Therapeutic role of melatonin in migraine prophylaxis: Is there a link between sleep and migraine?

  2020cites this paper
• Physiological and pharmacological perspectives of melatonin

  2020cites this paper
• Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial.

  2020cites this paper
• Melatonin as an Anti-Cancer Molecule: A Retrospective Perspective

  2020cites this paper
• Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS).

  2020cites this paper
• Melatonin: Clinical Perspectives in Neurodegeneration

  2019cites this paper
• Smith-Magenis Syndrome: Molecular Basis of a Genetic-Driven Melatonin Circadian Secretion Disorder

  2019cites this paper
• Far-3infrared Ray-mediated Antioxidant Potentials are Important for 
Attenuating Psychotoxic Disorders

  2019cites this paper
• Melatonin Increases Brown Adipose Tissue Volume and Activity in Patients With Melatonin Deficiency: A Proof-of-Concept Study

  2019cites this paper
• Melatonin use in an inpatient academic medical center: Factors affecting provider documentation of patients' sleep quality.

  2019cites this paper
• Are melatonin doses employed clinically adequate for melatonin-induced cytoprotection?

  2019cites this paper
• The effects of bioavailable omega-3 polyunsaturated fatty acids, delivered at bedtime, on brain function, sleep, cognition and mood in healthy adults

  2019cites this paper
• British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update

  2019cites this paper
• Protocol: Using N-of-1 tests to identify responders to melatonin for sleep disturbance in Parkinson's disease

  2019cites this paper
• The circadian clock at the intercept of sleep and pain.

  2019cites this paper
• Association of the melatonin circadian rhythms with clock 3111T/C gene polymorphism in Caucasian and Asian menopausal women with insomnia

  2018influential citation
• [Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin®) in insomnia].

  2018cites this paper
• [Disturbances in melatonin secretion and the efficacy of replacement therapy in sleep disorders].

  2018cites this paper
• Melatonin and Major Neurocognitive Disorders: Beyond the Management of Sleep and Circadian Rhythm Dysfunction

  2018cites this paper
• Mélatonine : aspects physiologiques et pharmacologiques en relation avec le sommeil, intérêt d’une forme galénique à libération prolongée (Circadin®) dans l’insomnie

  2018cites this paper
• Insomnia But Not Hypnotics Use Associates with the Risk of Breast Cancer: A Population-Based Matched Cohort Study

  2018cites this paper
• Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 Diabetes and Cancer.

  2017cites this paper
• Analysis of Different Melatonin Secretion Patterns in Children With Sleep Disorders: Melatonin Secretion Patterns in Children

  2017cites this paper
• A review of sleep disorders and melatonin

  2017cites this paper
• Kraftquelle Schlaf

  2017cites this paper
• Melatonin Synthesis in Fermented Foods

  2017cites this paper
• New Galenic Formulations of Melatonin

  2016cites this paper
• Circadian Melatonin Rhythm Following Traumatic Brain Injury

  2016cites this paper
• MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.

  2016cites this paper
• Sleep Quality and Recommended Levels of Physical Activity in Older People.

  2016cites this paper
• Melatonin: A Potential Anti-Oxidant Therapeutic Agent for Mitochondrial Dysfunctions and Related Disorders.

  2016cites this paper
• Melatonin and Sleep in Humans

  2016cites this paper
• Melatonin in sleep-wake regulation

  2016cites this paper
• Melatonergic Drug Ramelteon in Neurotherapeutics

  2016cites this paper
• Опыт коррекции климактерических симптомов и качества сна с помощью мелатонина

  2016cites this paper
• Insomnia (primary) in older people: non-drug treatments.

  2015cites this paper
• Therapeutical Implications of Melatonin in Alzheimer’s and Parkinson’s Diseases

  2015cites this paper
• The Influence of Light on Mood

  2015cites this paper
• Comparisons of Objective Sleep Quality Between Elderly Individuals With and Without Cataract Surgery: A Cross-Sectional Study of the HEIJO-KYO Cohort.

  2015cites this paper
• The potential physiological crosstalk and interrelationship between two sovereign endogenous amines, melatonin and homocysteine.

  2015cites this paper
• Retardiertes Melatonin in der Behandlung der primären Insomnie

  2015influential citation
• [Hypnotics--state of the science].

  2014cites this paper
• Optimal Dosages for Melatonin Supplementation Therapy in Older Adults: A Systematic Review of Current Literature

  2014cites this paper
• Melatonin: an internal signal for daily and seasonal timing.

  2014cites this paper
• Possible Role of Exogenous Melatonin and Melatonin-Receptor-Agonists in the Treatment of Menopause―Associated Sleep Disturbances

  2014cites this paper
• Melatonin and glucose metabolism: clinical relevance.

  2014cites this paper
• Melatonin Therapy in Patients with Alzheimer’s Disease

  2014cites this paper
• 3．術前門脈枝塞栓術の実際：a） 経皮的アプローチ

  2014cites this paper
• Évaluation de l'impact du mode ventilatoire sur le sommeil des patients de réanimation : étude de faisabilité

  2014cites this paper
• Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders

  2014cites this paper
• Melatonin and Its Agonists in Sleep Disorders

  2014cites this paper
• Hypnotika – Stand der Forschung

  2013cites this paper
• Manipulating the sleep-wake cycle and circadian rhythms to improve clinical management of major depression

  2013cites this paper
• Sleep and circadian rhythm dysregulation in schizophrenia.

  2013cites this paper
• Melatonin and mitochondrial dysfunction in the central nervous system.

  2013cites this paper
• Treatment of resistant insomnia and major depression.

  2013cites this paper
• Melatonin ameliorates cognitive impairment induced by sleep deprivation in rats: role of oxidative stress, BDNF and CaMKII.

  2013cites this paper
• Study of photodegradation kinetics of melatonin by multivariate curve resolution (MCR) with estimation of feasible band boundaries.

  2013cites this paper
• Melatonin prolonged release: a guide to its use in the treatment of insomnia in patients aged ≥55 years

  2013cites this paper
• Hypnotika - Stand der Forschung

  2013cites this paper
• Etude du récepteur humain de la mélatonine MT1 par des approches in vitro : mise au point des conditions de production, de purification et de caractérisation fonctionnelle

  2013cites this paper
• Melatonin Prolonged Release

  2012cites this paper
• New developments in the treatment of primary insomnia in elderly patients: focus on prolonged-release melatonin

  2012cites this paper
• Fractional Wavelet Transform–Continous Wavelet Transform for the Quantification of Melatonin and Its Photodegradation Product

  2012cites this paper
• Agomelatine in depressive disorders: its novel mechanisms of action.

  2012cites this paper
• Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia

  2012cites this paper
• Melatonin and its analogs in insomnia and depression

  2012cites this paper
• Drugs for insomnia

  2012cites this paper
• New developments in the treatment of primary insomnia in elderly patients: focus on prolonged-release melatonin

  2012cites this paper